Cataract
+1
Phaco-UCP Versus Phaco Alone for OAG and Cataract
Sponsored by Ameera Gamal Abdelhameed
About this trial
Last updated 6 years ago
Study ID
Phaco-UCP in OAG and cataract
Status
Completed
Type
Interventional
Phase
N/A
Placebo
No
Accepting
40 to 80 Years
All Sexes
Trial Timing
Ended 6 years ago
What is this trial about?
This study was carried out to evaluate the safety and efficacy of combined phacoemulsification and Ultrasound ciliary plasty (Phaco-UCP) as a first-line surgical treatment of coexisting cataract and op
/en angle glaucoma compared to phacoemulsification alone. To our knowledge, this is the first report of results of combined Phaco-UCP
What are the participation requirements?
Inclusion Criteria
* patients diagnosed with POAG or pseudoexfoliation glaucoma with coexisting visually significant cataract that required phacoemulsification
Exclusion Criteria
* patients with any other type of glaucoma, including narrow angle glaucoma, neovascular, uveitic or angle recession glaucoma, patients with advanced glaucoma characterized by advanced optic disc cupping or visual field damage, history of glaucoma or intraocular surgery and other ocular diseases that would affect safety or interfere with the procedure. We also excluded patients with incomplete follow-up or missing data